Recommendations for pneumococcal immunization outside routine childhood immunization programs in Western Europe.

ABSTRACT: The global burden of pneumococcal diseases is high, with young children and adults≥50 years of age at highest risk of infection. Two types of vaccine are available for the prevention of pneumococcal diseases caused by specific Streptococcus pneumoniae serotypes: the pneumococcal polysaccharide vaccine (PPV23) and the pneumococcal conjugate vaccine (PCV7, PCV10, and PCV13). Despite pneumococcal immunization programs in adults and children, the burden in adults has remained high. Most European countries have national or local/regional vaccination recommendations. The objective of this review was to provide an overview of the government recommendations for pneumococcal vaccination outside routine childhood vaccination programs for 16 Western European countries as of August 2014. We found that

SUBMITTER: Castiglia P 

PROVIDER: S-EPMC4209094 | biostudies-literature | 2014 Oct

REPOSITORIES: biostudies-literature